Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.845 NOK
−201.06 M NOK
0.00 NOK
14.97 M
About ZELLUNA ASA
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs that require an ongoing T cell response for their mode of action. Ultimovacs is performing a broad clinical development program with clinical trials in Europe and the USA. The company and its proprietary technology are based on pre-clinical and clinical research on immunotherapies conducted at the Oslo University Hospital. The company is a limited public liability company listed on the Oslo Stock Exchange in Norway.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ZLNA is 2.195 NOK — it has increased by 0.47% in the past 24 hours. Watch ZELLUNA ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange ZELLUNA ASA stocks are traded under the ticker ZLNA.
ZLNA stock has risen by 2.38% compared to the previous week, the month change is a 2.38% rise, over the last year ZELLUNA ASA has showed a 4.52% increase.
We've gathered analysts' opinions on ZELLUNA ASA future price: according to them, ZLNA price has a max estimate of 7.00 NOK and a min estimate of 7.00 NOK. Watch ZLNA chart and read a more detailed ZELLUNA ASA stock forecast: see what analysts think of ZELLUNA ASA and suggest that you do with its stocks.
ZLNA stock is 7.32% volatile and has beta coefficient of 1.32. Track ZELLUNA ASA stock price on the chart and check out the list of the most volatile stocks — is ZELLUNA ASA there?
Yes, you can track ZELLUNA ASA financials in yearly and quarterly reports right on TradingView.
ZELLUNA ASA is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
ZLNA net income for the last quarter is −107.72 M NOK, while the quarter before that showed −25.83 M NOK of net income which accounts for −317.08% change. Track more ZELLUNA ASA financial stats to get the full picture.
No, ZLNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 6, 2025, the company has 12.00 employees. See our rating of the largest employees — is ZELLUNA ASA on this list?
Like other stocks, ZLNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZELLUNA ASA stock right from TradingView charts — choose your broker and connect to your account.